The potential clinical impact of probiotic treatment for the prevention and/or anti-inflammatory therapeutic effect against radiation induced intestinal mucositis. A review

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 3, Issue 3, 2009, Pages 195-200

  Maria Aggeliki, Kalogeridi S ^a   Nikolaos, Kelekis L ^a   George, Kyrias M ^b   Vassilis, Kouloulias E ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Diarrhoea; Intestinal mucositis; Pelvis; Probiotics; Radiotherapy

Indexed keywords

AMIFOSTINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACEBO; PROBIOTIC AGENT; VSL3;

ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; BACTEREMIA; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; CANCER RADIOTHERAPY; CLINICAL TRIAL; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENTERITIS; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE MOTILITY; INTESTINE MUCOSA; LACTOBACILLUS; MICROBIAL COLONIZATION; MUCOSA INFLAMMATION; NONHUMAN; PATENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; REVIEW; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS; SURGICAL INFECTION;

ANTI-INFLAMMATORY AGENTS; HUMANS; INTESTINAL MUCOSA; MUCOSITIS; PATENTS AS TOPIC; PROBIOTICS; RADIATION INJURIES; RADIOTHERAPY;

EID: 70350746662     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221309789257432     Document Type: Review

References (91)

1. Keefe DM, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-637.
2. Husebye E, Skar V, Hoverstad T, Iversen T, Melby K. Abnormal intestinal motor patterns explain enteric colonization with gramnegative bacilli in late radiation enteropathy. Gastroenterology 1995; 109: 1078-1089.
3. Gelfand MD, Tepper M, Katz LA, et al. Acute radiation proctitis in man: Development of eosinophilic crypt abscesses. Gastroenterology 1968; 54: 401-411.
4. Andreyev HJ, Vlavianos P, Blake P, Dearnaley D, Norman AR, Tait D. Gastrointestinal symptoms after pelvic radiotherapy: Role for the gastroenterologist? Int J Radiat Oncol Biol Phys 2005; 62: 1464-14671.
5. Karlsdottir A, Muren LP, Wentzel-Larsen T, Dahl O. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys 2008; 70: 1478-1486.
6. Abayomi J, Kirwan J, Hackett A. The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life. Eur J Oncol Nurs 2009; [Epub ahead of print].
7. Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhoea. J Clin Oncol 2004; 22: 2918-2926.
8. Muehlbauer PM, Thorpe D, Davis A, Drabot R, Rawlings BL, Kiker E. Putting evidence into practice: Evidence-based interventions to prevent, manage and treat chemotherapy- and radiotherapy- induced diarrhoea. Clin J Oncol Nurs 2009; 13: 336-341.
9. Bismar MM, Sinicrope FA. Radiation enteritis. Curr Gastroenterol Rep 2002; 4: 361-365.
10. Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach M. 3rd intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2006; 66: 654-662.
11. Vargas C, Martinez A, Kestin LL, et al. Dose-volume analysis of predictors of chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 1297-1308.
12. Jereczek-Fossa BA, Badzio A, Jassem J. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol 2003; 68: 33-39.
13. Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and baldder using intensitymodulated radiotherapy. Acta Oncol 2009; 48: 238-244.
14. Zimmerer T, Bocker U, Wenz F, Singer MV. Medical prevention and treatment of acute and chronic radiation-induced enteritis - is there any proven therapy? A short review. Z Gastroenterol 2008; 46: 441-448.
15. Varela E, Antolin M, Guarner F, Verges R, Giralt J, Malagelada JR. Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy. Aliment Pharmacol Ther 2009; 30: 175-185.
16. Sanguineti G, Endres EJ, Sormani MP, Parker BC. Dosimetric predictors of diarrhoea during radiotherapy for prostate cancer. Strahlenther Onkol 2009; 185: 390-396.
17. Wedlake L, Thomas K, Mc Gough C, Andreyev HJ. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observation study. Eur J Cancer 2008; 44: 2212-2217.
18. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: Are they of any importance? Gut 2005; 54: 1051-1054.
19. McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 2004; 90: 2278-2287.
20. Donaldson SS, Jundt S, Ricour C, Sarrazin D, Lemerie J, Schweisguth O. Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management. Cancer 1975; 35: 1167-1178.
21. Zeng W, Miao W. Development of small molecular probes for the molecular imaging of apoptosis. Anticancer Agents Med Chem 2009 (in press).
22. Potten CS, Booth C. The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: A brief review. Comp Biochem Physiol B Biochem Mol Biol 1997; 118: 473-478.
23. Potten CS, Grant HK. The relation between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br J Cancer 1998; 78: 993-1003.
24. Potten CS, Merritt A, Hickman J, Hall P, Faranda A. Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radiat Biol 1994; 65: 71-78.
25. Sher ME, Bauer J. Radiation-induced enteropathy. Am J Gastroenterol 1990; 85: 121-128.
26. Blanarova C, Galovicova A, Petrasova D. Use of probiotics for prevention of radiation-induced diarrhoea. Bratisl Lek Listy 2009; 110: 98-104.
27. Gunter-Smith PJ. The effect of radiation on intestinal electrolyte transport. In: Dupois A, King GL, Livengood DR, Eds. Radiation and the gastrointestinal Tract. Baca Raton: CRC Press 1995: 149-160.
28. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519.
29. Hao WL, Lee YK. Microflora of the gastrointestinal tract: A review. Methods Mol Biol 2004; 268: 491-502.
30. Benno Y, Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microfi 1986; 5: 13-25.
31. Tannock GW. Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R & D. Trends Biotechnol 1997; 15: 270-274.
32. Giralt J, Regadera JP, Verges R, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhoea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008; 71: 1213-1219.
33. Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol 1997; 32: 556-563.
34. Quigley EM, Quera R. Small intestinal bacterial overgrowth: role of antibiotics, prebiotics ans probiotics. Gastroenterology 2006; 130 (2 Suppl 1): S78-S90.
35. Glassen J, Belka C, Paulsen F, Budah W, Hoffman W, Bamberg M. Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol 1998; 174(Suppl3): 82-84.
36. Otterson MF. Effects of radiation upon gastrointestinal motility. World J Gastroenterol 2007; 13: 2684-2692.
37. Molla M, Panes J. Radiation-induced inflammation. World J Gastroenterol 2007; 13: 3043-3046.
38. Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1111-1117.
39. Lee SJ, Dimtchev A, Lavin MF, Dritschilo A, Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 1998; 17: 1821-1826.
40. Yeoh A, Bowen J, Gibson RD. Nuclear factor ??B (NF??B) and cyclooxygenase-2 (COX-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int J Radiat Oncol Biol Phys 2005; 63: 1295-1303.
41. Sinis ST. Pathobiology of mucositis. Semin Oncol Nurs 2004; 40: 170-176.
42. Famularo G, De Simone C, Matteuzzi D, Pirovano F. Traditional and high potency probiotic preparations for oral bacteriotherapy. Biodrugs 1999; 12: 455-470.
43. Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C. Probiotic lactobacilli: A new perspective for the treatment of inflammatory bowel disease. Curr Pharm Des 2003; 9: 1973-1980.
44. Lee YK, Salminen S. The coming of age of probiotics. Trends Food Sci Technol 1995; 6: 241-245.
45. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004; 126: 1358-1373.
46. Madsen K, Cornish A, Soper P, et al. Probiotc bacteria enhance murine and human epithelial barrier function. Gastroenterology 2001; 121: 580-591.
47. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132: 562-575.
48. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276(4 Pt 1): G941-950.
49. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52: 827-833.
50. Fuccio L, Guido A, Eusebi LH, et al. Effects of probiotics for the prevetion and treatment of radiation-induced diarrhoea. J Clin Gastroenterol 2009; 43: 506-513.
51. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhoea. World J Gastrenterol 2007; 13: 912-915.
52. Dall'Era MA, Hampson NB, Hsi RA, Madsen B, Corman JM. Hyperbaric oxygen therapy for radiation induced proctopathy in men treated for prostate cancer. J Urol 2006; 176: 87-90.
53. Marshall GT, Thirlby RB, Bredfeldt JE, Hampson NB. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med 2007; 34: 35-42.
54. Martenson JA, Halyard MY, Sloan JA, et al. Phase III, doubleblind study of depot octreotide versus placebo in the prevention of acute diarrhoea in patients receiving pelvic radiation therapy: Results of North Central Cancer Treatment Group N00CA. J Clin Oncol 2008; 10: 5248-5253.
55. Matsuu-Matsuyama M, Shichijo K, Okaichi K, et al. Sucralfate protects intestinal epithelial cells from radiation-induced apoptosis in rats. J Radiat Res 2006; 47: 1-8.
56. Diestel CF, Marques RG, Lopes-Paulo F, et al. Role of Lglutamine and glycine supplementation on irradiated colonic wall. Int J Colorectal Dis 2007; 22: 1523-1529.
57. Denton AS, Andreyev HJ, Forbes A, Mahler EJ. Systematic review for non-surgical interventions for the management of late radiation proctitis. Br J Cancer 2002; 87: 134-143.
58. Hovdenak N, Sørbye H, Dahl O. Sucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis. Clin Oncol (R Coll Radiol) 2005; 17(6): 485-491.
59. Ménard C, Camphausen K, Muanza T, et al. Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results. Semin Oncol 2003; 30(6 Suppl 18): 63-67.
60. Simone NL, Ménard C, Soule BP, et al. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvement in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys 2008; 70: 90-95.
61. Singh AK, Ménard C, Guion P, et al. Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: A pilot study. Int J Radiat Oncol Biol Phys 2006; 65: 1008-1013.
62. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhoea in infants and children: A systematic review of published, double blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; (33 Suppl 2): S 17-25.
63. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhoea: A meta-analysis of randomized placebo-controlled trials. CMAJ 2006; 175: 377-383.
64. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14: 2650-2661.
65. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: Probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 16: 9-15.
66. Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007; 115: 1-11.
67. Hedin C, Whelan K, Lindsa JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66: 307-315.
68. Kanauchi O, Mitsuyama K, Andoh A. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 2074-2086.
69. Hauer A. Probiotics in allergic diseases of childhood. MMW Fortschr Med 2006; 148: 34-36.
70. Gupta V, Garg R. Probiotics. Indian J Med Microbiol 2009; 27: 202-209.
71. Gill H, Prasad J. Probiotics, immunomodulation and helath benefits. Adv Exp Med Biol 2008; 606: 423-454.
72. de Vrese M, Marteau P. Probiotics and prebiotics: Effects on diarrhoea. J Nutr 2007; 137(3Suppl 2): 803S-811S.
73. Bengmark S, Gil A. Bioecological and nutritional control of disease: Prebiotics, probiotics and synbiotics. Nutr Hosp 2006; 21(Suppl 2): 72-84.
74. Gionchetti P, Amadini C, Rizzello F, et al. Probiotics -role in inflammatory bowel disease. Digest Liver Dis 2002; 34 (Suppl 2): S58-S62.
75. Kopp MV, Salfeld P. Probiotics and prevention of allergic disease. Curr Opin Clin Nutr Metab Care 2009; 12: 298-303.
76. Southcott E, Tooley KL, Howarth GS, Davidson GP, Butler RN. Yogurt containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig Dis Sci 2008; 53: 1837-1841.
77. Mauger CA, Butler RN, Geiger MS, Tooley KL, Howarth GS. Probiotics effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Dig Dis Sci 2007; 52: 612-619.
78. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss. Cancer Biol Ther 2007; 6: 1449-1454.
79. Seal M, Naito Y, Barreto R, Lorenzetti A, Safran P, Marotta F. Experimental radiotherapy-induced enteritis: A probiotic interventional study. J Dig Dis 2007; 8: 143-147.
80. Demirer S, Aydintug S, Aslim B, et al. Effects of probiotics on radiation-induced injury in rats. Nutrition 2006; 22: 179-186.
81. Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435-437.
82. De Simone, C.: WO03013558A1 (2003).
83. Delia P, Sansotta G, Donato V, et al. Prevention of radiationinduced diarrhoea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 2002: 97: 2150-2152.
84. Piene J. Y.: EP1696937A1 (2006).
85. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-297.
86. Kunze, W., Bienenstock, J., Forsythe, P.: WO2008064489 A1 (2008).
87. Urbancsek H, Kazar T, Mezes I, Neumann K. Results of a doubleblind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 391-396.
88. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: A prospective study investigating assocjiation between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-228.
89. Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K, Snelling AM. Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 2007; 26: 208-215
90. Liong MT. Safety of probiotics: Translocation and infection. Nutr Rev 2008; 66: 192-202.
91. Pham M, Lemberg DA, Day AS. Probiotics: Sorting evidence from the myth. Med J Aust 2008; 188: 304-308.